Introduction
============

Adipose tissue is an important endocrine organ that secretes many bioactive substances (adipocytokines). One of these, adiponectin, has many favorable effects on metabolism, including improvement of insulin action and reduction of atherosclerotic processes ([@B13]; [@B19]). Unlike other adipocytokines, the plasma level of adiponectin is reduced in obese individuals ([@B18]; [@B32]). We previously reported that mitochondrial function is essential for adiponectin synthesis in adipocytes, and that mitochondrial dysfunction in adipose tissue explains decreased adiponectin synthesis in obesity ([@B19]). Of particular interest in this study was the observation that impaired mitochondrial function activates a series of mechanisms involving endoplasmic reticulum (ER) stress, c-Jun N-terminal kinases (JNK), and activating transcription factor 3 (ATF3) to decrease adiponectin synthesis.

Nitric oxide (NO) is produced from L-arginine by the enzymatic action of NADPH-dependent NO synthases (NOS) ([@B4]). Among the known isoforms of NOS, activation of endothelial NOS (eNOS) is necessary for mitochondrial biogenesis ([@B26]) and adiponectin synthesis ([@B20]). Inducible NOS (iNOS) is also expressed in adipose tissue ([@B8]), and iNOS expression is increased in adipose tissues in genetic and dietary models of obesity ([@B28]). In addition, obese mice lacking iNOS are sensitized to the metabolic actions of rosiglitazone, a peroxisome proliferator-activated receptor-γ (PPARγ) agonist, that result in increased plasma adiponectin levels ([@B7]).

Plasma levels of free fatty acids (FFAs) are increased in obese individuals and those with type 2 diabetes ([@B2]). FFAs have been shown to cause mitochondrial dysfunction and ER stress ([@B10]; [@B30]). In particular, saturated fatty acids, i.e., palmitate and stearate, induce inflammation and insulin resistance in adipose tissue ([@B17]), whereas polyunsaturated fatty acids reduce body weight and insulin resistance ([@B14]; [@B3]). Palmitate also decreases adiponectin synthesis ([@B38]) and increases iNOS expression in adipocytes ([@B24]).

In this study, we investigated the role of iNOS activation in the palmitate-induced decrease in adiponectin synthesis. As excessive NO produced by iNOS was shown to increase mitochondrial damage ([@B11]), we hypothesized that palmitate-induced activation of iNOS would be primarily responsible for mitochondrial dysfunction and ER stress, and the consequent decrease in adiponectin synthesis. As expected, palmitate-induced iNOS expression was responsible for ER stress and decreased adiponectin synthesis. However, iNOS did not affect mitochondrial contents, and conversely, palmitate-induced mitochondrial dysfunction was responsible for iNOS induction.

Results
=======

Palmitate decreases adiponectin synthesis and increases iNOS expression in cultured adipocytes
----------------------------------------------------------------------------------------------

As reported previously ([@B38]), palmitate significantly decreased adiponectin expression in 3T3L1 adipocytes and its secretion into culture media ([Figure 1A](#F1){ref-type="fig"}). Additionally, in agreement with a previous study ([@B24]), palmitate increased iNOS expression in cultured adipocytes ([Figure 1B](#F1){ref-type="fig"}), and this was associated with increased NO synthesis by adipocytes as measured by the nitrite concentration in the media ([Figure 1C](#F1){ref-type="fig"}). Palmitate decreased mitochondrial DNA (mtDNA) contents ([Figure 1D](#F1){ref-type="fig"}) and the expression of mitochondrial respiratory proteins cytochrome C oxidase and cytochrome C ([Figure 1B](#F1){ref-type="fig"}). Palmitate also decreased ATP levels and increased reactive oxygen species (ROS) generation ([Figures 1E and F](#F1){ref-type="fig"}).

Inhibition of iNOS reverses palmitate-induced ER stress response but does not affect mitochondrial contents
-----------------------------------------------------------------------------------------------------------

Excessive NO is known to inhibit electron flow in the mitochondrial electron transport chain (ETC) and to increase ROS production and mitochondrial damage ([@B3]). We therefore reasoned that iNOS inhibition would recover palmitate-induced decreases in mtDNA contents and mitochondrial protein expression. As expected, S-methylisothiourea sulfate (SMT), an iNOS-specific inhibitor, inhibited NO synthesis ([Figure 2A](#F2){ref-type="fig"}), and recovered the palmitate-induced decrease in adiponectin expression ([Figure 2B](#F2){ref-type="fig"}) and secretion into media ([Figure 2C](#F2){ref-type="fig"}). However, contrary to our expectation, treatment with SMT did not affect mitochondrial DNA content ([Figure 2D](#F2){ref-type="fig"}) or the expression of mitochondrial proteins ([Figure 2E](#F2){ref-type="fig"}).

As previously reported ([@B24]), palmitate significantly increased the levels of ER stress response markers (anti-CCAAT/enhancer-binding protein (CHOP) and X-box binding protein 1 (XBP1) splicing) and the phosphorylation of JNK, a downstream signaling molecule of the ER stress response shown to be involved in adiponectin synthesis ([@B19]) in cultured adipocytes ([Figure 2F](#F2){ref-type="fig"}). Inhibition of iNOS by SMT nearly completely reversed palmitate-induced changes in the ER stress response and JNK. Taken together, these results suggest that palmitate-induced activation of iNOS is responsible for the ER stress response and decreased adiponectin synthesis in cultured adipocytes, but is not responsible for changes in mitochondrial contents.

Mitochondrial dysfunction decreases adiponectin synthesis by increasing iNOS expression
---------------------------------------------------------------------------------------

We previously showed that various chemicals that inhibit mitochondrial function \[indinavir, chloramphenicol, tumor necrosis factor-α (TNF-α), carbonyl cyanide m-chlorophenyl hydrazone (CCCP), and oligomycin\] reduce adiponectin synthesis, and increase the ER stress response ([@B19]). To determine whether this effect is mediated by iNOS, we examined the effects of these chemicals on iNOS expression. iNOS expression was significantly increased by these chemicals ([Figure 3A](#F3){ref-type="fig"}). SMT significantly decreased XBP1 splicing induced by these chemicals ([Figure 3B](#F3){ref-type="fig"}) and increased adiponectin synthesis ([Figure 3C](#F3){ref-type="fig"}).

Increased mitochondrial biogenesis decreases iNOS expression in cultured adipocytes
-----------------------------------------------------------------------------------

We next questioned whether the palmitate-induced increase in iNOS expression is mediated by mitochondrial dysfunction. Increased mitochondrial biogenesis improves mitochondrial function ([@B33]; [@B35]), and rosiglitazone increases adiponectin synthesis in adipocytes by increasing mitochondrial biogenesis ([@B19]). In this study, we examined the effects of mtTFA siRNA on rosiglitazone-induced changes in iNOS expression. As expected ([@B37]; [@B19]), rosiglitazone increased adiponectin secretion, and this was accompanied by a decrease in the expression of iNOS in cultured 3T3L1 adipocytes ([Figures 4B and 4C](#F4){ref-type="fig"}). These effects of rosiglitazone were significantly lower in cells pre-treated with siRNA against mitochondrial transcription factor A (mtTFA), a mitochondrial matrix protein essential for the replication and transcription of mtDNA ([@B16]) ([Figures 4A-4C](#F4){ref-type="fig"}). To further confirm the reducing effect of increased mitochondrial biogenesis on iNOS expression, we examined the effect of nuclear respiratory factor-1 (NRF-1) overexpression. NRF-1 is a transcription factor that regulates the expression of nuclear-encoded mitochondrial genes, including mtTFA. Adenovirus-mediated overexpression of NRF-1 (Ad-NRF-1) decreased iNOS expression in the presence of palmitate, and this was accompanied by an increase in adiponectin synthesis ([Figures 4D and 4E](#F4){ref-type="fig"}). siRNA against mtTFA reversed the effects of Ad-NRF-1 on iNOS expression and adiponectin synthesis ([Figures 4D and 4E](#F4){ref-type="fig"}). Together, these results suggest that mitochondrial dysfunction induces ER stress by increasing iNOS expression in adipocytes, and that improved mitochondrial function by mitochondrial biogenesis reduces iNOS expression and increases adiponectin synthesis.

Discussion
==========

Accumulating evidence indicates that NO produced by NOS plays a crucial role in energy metabolism ([@B15]). Among the known types of NOS, iNOS produces high concentrations of NO in response to various inflammatory signals ([@B25]). iNOS is also expressed in tissues other than inflamed tissues, and its expression is increased in adipose tissue and muscle in animal models of dietary and genetic obesity ([@B41]; [@B28]). iNOS-/- mice are protected from high fat-induced insulin resistance ([@B28]).

Mitochondrial function was shown to be essential for adiponectin synthesis in adipocytes ([@B19]). In the present study, we showed that palmitate-induced mitochondrial dysfunction induced iNOS expression, and that this was responsible for ER stress and reduced adiponectin synthesis in cultured 3T3L1 adipocytes. Our results are consistent with those of a previous study, which showed that excessive NO downregulates the gene expression and secretion of adiponectin ([@B27]). A recent study also showed that the effect of rosiglitazone on adiponectin levels was markedly increased in iNOS-/- mice ([@B7]).

Excessive NO in the cell has been shown to increase mitochondrial damage and to cause mitochondrial dysfunction by inhibiting mitochondrial ETC ([@B3]). We therefore reasoned that iNOS inhibitor would recover palmitate-induced decreases in mtDNA and mitochondrial protein expression. As expected ([@B5]; [@B30]), palmitate significantly decreased mtDNA content and mitochondrial protein levels. However, iNOS inhibition by SMT did not increase mtDNA content or the expression of mitochondrial respiratory proteins. In our study, chemicals that cause mitochondrial dysfunction induced iNOS expression in cultured adipocytes. Although this particular experiment has not been performed before, this is consistent with previous studies ([@B39]; [@B21]).

In this study, we found that rosiglitazone, a PPARγ agonist, decreased iNOS expression in cultured adipocytes. This finding is consistent with previous studies: various PPARγ agonists have been shown to inhibit iNOS expression in islet cells ([@B1]), myocardium ([@B23]), lung ([@B6]), and 3T3L1 adipocytes, and in the epididymal fat of Otsuka Long-Evans Tokushima Fatty rats ([@B22]). PPARγ agonists increase mitochondrial biogenesis ([@B37]; [@B19]), and increased mitochondrial biogenesis is known to improve mitochondrial function ([@B3]). Our data, which indicate that rosiglitazone and Ad-NRF-1 reversed the palmitate-induced increase in iNOS expression, and that treatment with siRNA against mtTFA reversed the rosiglitazone- and Ad-NRF-1-induced decreases in iNOS expression, suggest that palmitate-induced mitochondrial dysfunction is responsible for iNOS induction.

Palmitate was shown to induce iNOS production ([@B34]), mitochondrial dysfunction ([@B40]) and ER stress ([@B9]). The novelty of our study is that we showed the sequence of these events. We provided new evidence that mitochondrial dysfunction is the primary cause of iNOS induction, ER stress response and decreased adiponectin synthesis ([Supplemental Figure S1](#S1){ref-type="supplementary-material"}). However, excessive NO in the cell is known to increase mitochondrial damage and to cause mitochondrial dysfunction by inhibiting mitochondrial electron-transfer complexes ([@B3]). This effect of NO may help the cells withstand severe stress by reducing intracellular ROS generation ([@B29]). However, it may also result in a vicious cycle, in which mitochondrial dysfunction leads to iNOS induction, NO increases, and further mitochondrial dysfunction.

In summary, we have demonstrated that palmitate-induced mitochondrial dysfunction induces iNOS expression and the ER stress response, and reduces adiponectin synthesis in cultured adipocytes. Increases in mitochondrial biogenesis by Ad-NRF-1 or rosiglitazone decreased iNOS expression and ER stress, and this was reversed by siRNA against mtTFA. The iNOS inhibitor SMT increased adiponectin synthesis by reducing ER stress, but did not affect mitochondrial contents. Taken together, these results suggest that palmitate-induced mitochondrial dysfunction is the primary event that leads to iNOS induction, ER stress, and decreased adiponectin synthesis in cultured adipocytes. Excessive NO produced by iNOS links mitochondrial dysfunction to ER stress and decreased adiponectin synthesis.

Methods
=======

Cell culture
------------

3T3L1 fibroblasts were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 10% fetal bovine serum in an incubator with 5% CO~2~/95% O~2~ at 37℃. 3T3L1 pre-adipocytes were differentiated to mature adipocytes by a conventional method ([@B19]) and were maintained as subconfluent cultures.

Measurement of adiponectin concentration
----------------------------------------

Adiponectin concentrations in the culture media were measured by an enzyme-linked immunosorbent assay (ELISA) kit (Alpco Diagnostics, Salem, NH) according to the manufacturer\'s instructions.

Measurement of nitrite concentration
------------------------------------

Nitrite concentrations in the culture media were measured by the Total Nitric Oxide Assay kit (Assay Designs, Ann Arbor, MI) according to the manufacturer\'s instructions.

Measurement of ROS levels
-------------------------

Intracellular ROS generation was measured by flow cytometry using DCFH2-DA (Molecular Probes, Eugene, OR). For measurement of intracellular ROS levels, cells were incubated for 15 min with 2.5 µmol/ml DCFH2-DA at 37℃ for 30 min. The increase in DCFH2-DA oxidation was measured by a flow cytometry (FACSCalibur, San Jose, CA). Fluorescence was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm.

Measurement of intracellular ATP levels
---------------------------------------

Intracellular ATP levels were measured using an ATP determination kit (BioVision, Mountain View, CA) according to manufacturer\'s instructions.

Western blot analysis
---------------------

Differentiated 3T3L1 cells were lysed in a buffer containing 20 mM Tris-HCl (pH 7.4), 1 mM EDTA, 140 mM NaCl, 1% NP-40, 1 mM Na~3~VO~4~, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaF, and 10 µg/ml aprotinin. The protein (40-50 µg) was subjected to immunoblotting with specific antibodies. Antibodies against phospho-JNK and cytochrome C oxidase were from Cell Signaling Technology (Beverly, MA). Antibodies against CHOP and mtTFA antibody were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-iNOS, anti-cytochrome C antibody, and anti-β-actin were from BD Biosciences (San Jose, CA) and Sigma-Aldrich (St Louis, MO), respectively.

Analysis of spliced XBP1 mRNA
-----------------------------

XBP1 is a critical regulator of ER function and the ER stress response ([@B12]). Upon activation of the unfolded protein response, XBP1 mRNA is spliced by IRE1 to remove a 26-nucleotide intron and generate a translational frame shift. The resulting spliced mRNA (active form) encodes a protein with a novel carboxy-terminus that acts as a potent transcriptional activator. The target segment of the XBP1 cDNA was amplified by polymerase chain reaction (PCR) amplication. After separating the restriction digests, the cDNA fragments were resolved on 2% agarose gel. XBP1 splicing was measured by PCR using the following primers: forward, 5\'-AAACAGAGTAGCAGCGCA GACTGC-3\', reverse, 5\'-GGATCTCTAAAACTAGAGGCTT GGTG-3\'. The PCR procedure included an initial incubation for 3 minutes at 92℃, followed by 40 cycles of 45 seconds at 92℃, 45 seconds at 52℃, and 45 seconds at 72℃, and a final incubation for 10 minutes at 72℃. The amplified fragment was then digested by the restriction endonuclease PstI for 2 hours at 37℃ to reveal a restriction site that is lost after IRE1-mediated cleavage and splicing of the mRNA. After separating the restriction digests, the cDNA fragments were resolved on a 2% agarose gel.

Small interfering RNA (siRNA)
-----------------------------

We designed two different siRNAs targeting different sequences of mtTFA: 5\'-GUACAUUUUGGGAAAGUAA-3\' and 5\'-GUCACUGACAAGUUUGCAAdTdT-3\'. We also made control siRNAs, which have the same GC content as the target sequences and do not cause silencing of gene expression (Bioneer, Daejon, Korea). Aliquots of 1.5 × 10^5^ cells were seeded into each well of 6-well plates and transfected with 100 pmol siRNA using lipofectamine (Invitrogen, Carlsbad, CA) according to the manufacturer\'s instructions.

Quantification of mtDNA content
-------------------------------

mtDNA contents were quantified by real-time PCR on an ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA) using a SYBR Green kit (Applied Biosystems) according to the manufacturer\'s protocol. Mouse nuclear 18S rRNA was used as the internal control. The ratio of the expression level of the target gene to that of the 18S rRNA was calculated by subtracting the Ct (threshold cycle) value of the target gene from the Ct value of 18S rRNA. Primers for detecting the cytochrome b gene (14,146-15,289) from the murine mitochondrial genome were designed on the basis of the GenBank nucleotide sequence. The primer sequences were: forward, 5\'- CCA CTT CAT CTT ACC ATT TA -3\'; reverse, 5\'-ATC TGC ATC TGA GTT TAA TC-3\' (GenBank AB042432.1, Mus musculus domesticus mitochondrion) ([@B19]).

Recombinant adenovirus
----------------------

NRF-1 adenovirus was a kind gift from Prof. Y. K. Pak (Kyung Hee University, Seoul, Korea).

Statistical analysis
--------------------

All values are given as mean ± SEM. Differences between two groups were assessed using unpaired two-tailed *t*-test. Data from more than two groups were assessed by analysis of variance (ANOVA) followed by a post-hoc least significant difference test. *P* \< 0.05 was considered statistically significant.
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![Effect of palmitate on adiponectin synthesis and iNOS expression in cultured adpocytes. Palmitate solutions containing 2% fatty acid-free bovine serum albumin were prepared in DMEM containing no serum. Differentiated 3T3L1 adipocytes were treated with palmitate (PA, 500 µM) for 24 hours. A 2% BSA control was included with or without palmitate. (A) Representative western blots of adiponectin expression in the cells and adiponectin levels in the culture media. (B) Effects of palmitate on the expression levels of iNOS and mitochondrial proteins in 3T3L1 adipocytes. COX IV, cytochrome C oxidase subunit II; Cyt C, cytochrome C. (C) Nitrate levels in the culture media, measured using the Griess Reagent System. (D) mtDNA contents measured by real-time PCR analysis. (E) Intracellular ATP levels measured by ATP fluorometric assay kit. (F) Intracellular ROS levels in response to PA treatment. Data in A, C, D, E and F are shown as means ± SEM (*n* = 5 each). ^\*^*P* \< 0.05 versus untreated cells.](emm-44-562-g001){#F1}

![iNOS inhibition by SMT reverses the inhibitory effect of palmitate on the expression of adiponectin. Differentiated 3T3L1 adipocytes were serum-deprived and cultured for 24 hours in the absence or presence of palmitate (PA, 500 µM) alone or in combination with SMT (30 µM). (A) Nitrate levels in the culture media. (B, C) Effect of iNOS inhibition on adiponectin synthesis. Representative Western blots and band density of adiponectin expression in the cells (B) and adiponectin levels in the culture media (C). (D, E) SMT does not affect mitochondrial contents. (D) mtDNA contents measured by real-time PCR analysis. (E) Representative Western blots and band density of mitochondrial proteins. (F) Effect of SMT on the ER stress response. Representative Western blots of CHOP and pJNK, and RT-PCR analysis of spliced XBP1 (S) and unspliced XBP1 (U) mRNA. Data in panels A-E are shown as means ± SEM (*n* = 5 each). ^\*^*P* \< 0.05 versus untreated cells; ^\#^*P* \< 0.05 versus palmitate-treated cells.](emm-44-562-g002){#F2}

![iNOS activation is responsible for ER stress induced by mitochondrial inhibitors. (A) Effect of mitochondrial inhibitors on iNOS expression in 3T3L1 adipocytes. Differentiated 3T3L1 adipocytes were treated with idinavir (Indi, 100 µM), chloramphenicol (Chlo, 100 µg/ml), TNF-α (TNF, 10 ng/ml), CCCP (0.4 µg/ml), and oligomycin (Oligo, 10 µg/ml) for 8 hours. (B, C) Effect of iNOS inhibition on ER stress and adiponectin synthesis. RT-PCR analysis of spliced XBP1 (S) and unspliced XBP1 (U) mRNA in the cells (B) and adiponectin levels in the media (C). Cells were co-treated with or without SMT (30 µM) and mitochondrial inhibitors (*n* = 6 per group). Data are shown as means ± SEM. ^\*^*P* \< 0.05 versus untreated cells; ^\#^*P* \< 0.05 versus chemicals-untreated cells.](emm-44-562-g003){#F3}

![Increased mitochondrial biogenesis decreases iNOS expression and increases adiponectin synthesis. (A-C) The effect of mtTFA siRNA on the rosiglitazone-induced decrease in iNOS expression. Two siRNAs targeting different sequences of mtTFA were made. 3T3L1 preadipocytes were transfected with 100 pmol of each mtTFA siRNA (mtTFA RNAi-A or B) or control siRNAs (Control RNAi), and then differentiated into mature adipocytes. The differentiated cells were treated with 500 µM palmitate (PA) with or without rosiglitazone (Rosi, 20 µM) for 24 hours. (A) Westen blot was used to confirm siRNA\'s target gene knockdown effect. (B) iNOS protein expression. (C) Adiponectin levels in culture media. Data are presented as mean ± SEM (*n* = 5 each). ^\*^*P* \< 0.05 versus control (with PA treatment); ^\#^*P* \< 0.05 versus control siRNA-transfected cells. (D, E) The effect of mtTFA siRNA on Ad-NRF-1-induced decrease in iNOS expression. 3T3L1 preadipocytes were transfected with 100 pmol mtTFA siRNA (mtTFA RNAi) or control siRNA. Following this, 3T3L1 preadipocytes were infected with adenoviruses carrying β-gal (Ad-β-gal) or NRF-1 (Ad-NRF-1) at a titer of 5 × 10^6^ pfu/ml for 1 hour at 37℃ without serum. 3T3L1 preadipocytes were then differentiated into mature adipocytes, and the differentiated cells were treated with 500 µM palmitate for 24 hours. (D) Representative Western blots and relative band densities of iNOS. (E) Adiponectin levels in the culture media. ^\*^*P* \< 0.05 versus Ad-β-gal-transfected cells; ^\#^*P* \< 0.05 versus control siRNA-transfected cells.](emm-44-562-g004){#F4}
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